Literature DB >> 8795130

Prevalence and characteristics of epilepsy in children in northern Sweden.

R Sidenvall1, L Forsgren, J Heijbel.   

Abstract

Active epilepsy was assessed in all children aged 0-16 years in an area of northern Sweden with about 250,000 inhabitants and around 50,000 children in the age group. One hundred and fifty-five children fulfilled the criteria of active epilepsy giving a prevalence rate of 4.2/1000. The proportion of boys to girls was 1:1.1. This dominance of girls had also been seen in a prospective study of incidence of epilepsy in the same area. Partial seizures were more common than generalized. Among the syndromes benign childhood epilepsy with centrotemporal spikes occurred in 17.4%, absence epilepsy in 6.5% and Lennox-Gastaut syndrome in 5.8%. Children with neurodeficit (ND) more often had generalized epileptic syndromes while the non-ND groups more often had localisation related syndromes. The aetiology was regarded to be remote symptomatic in 42%, idiopathic in 28% and cryptogenic in 30% of the children. Almost all children were on antiepileptic treatment, three quarters of them on monotherapy. Neurodeficit was noted in 42%. The prevalence of epilepsy and mental retardation was 1.7/1000. Relatively few children with neurodeficit had been seizure free during the last year, 43% had more than one seizures per month compared to 19% in the non-ND group.

Entities:  

Mesh:

Year:  1996        PMID: 8795130     DOI: 10.1016/s1059-1311(96)80108-7

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  18 in total

1.  Cranial computed tomography in partial motor seizures.

Authors:  Jageer Hussain; S Srinivasan; V Tiroumourougane Serane; S Mahadevan; S Elangovan; V Bhuvaneswari
Journal:  Indian J Pediatr       Date:  2004-07       Impact factor: 1.967

Review 2.  The descriptive epidemiology of epilepsy-a review.

Authors:  Poonam Nina Banerjee; David Filippi; W Allen Hauser
Journal:  Epilepsy Res       Date:  2009-04-15       Impact factor: 3.045

3.  Calming Down During Coming of Age.

Authors:  Jamie Maguire
Journal:  Epilepsy Curr       Date:  2017 Jan-Feb       Impact factor: 7.500

Review 4.  Learning disorders in children with epilepsy.

Authors:  Evangelos Pavlou; Anastasia Gkampeta
Journal:  Childs Nerv Syst       Date:  2010-11-16       Impact factor: 1.475

5.  Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy.

Authors:  Joseph Gonzalez-Heydrich; Jane Whitney; Deborah Waber; Peter Forbes; Olivia Hsin; Stephen V Faraone; Alice Dodds; Sneha Rao; Christine Mrakotsky; Carlene Macmillan; David R Demaso; Carl de Moor; Alcy Torres; Blaise Bourgeois; Joseph Biederman
Journal:  Epilepsy Behav       Date:  2010-05-21       Impact factor: 2.937

6.  Progressive dissociation of cortical and subcortical network development in children with new-onset juvenile myoclonic epilepsy.

Authors:  Camille Garcia-Ramos; Kevin Dabbs; Jack J Lin; Jana E Jones; Carl E Stafstrom; David A Hsu; Mary Elizabeth Meyerand; Vivek Prabhakaran; Bruce P Hermann
Journal:  Epilepsia       Date:  2018-10-03       Impact factor: 5.864

7.  Management of refractory complex partial seizures: current state of the art.

Authors:  David M Treiman
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

Review 8.  Health-related quality of life in childhood epilepsy: moving beyond 'seizure control with minimal adverse effects'.

Authors:  Gabriel M Ronen; David L Streiner; Peter Rosenbaum
Journal:  Health Qual Life Outcomes       Date:  2003-08-28       Impact factor: 3.186

9.  Access to antiepileptic drug therapy in children in Camagüey Province, Cuba.

Authors:  Zeina Bárzaga Arencibia; Alberto López Leyva; Yordanka Mejías Peña; Alba Rosa González Reyes; Maurilys Acosta Nápolez; Demetrio Carbonell Perdomo; Edita Fernández Manzano; Imti Choonara
Journal:  Int J Pharm Pract       Date:  2012-05-21

10.  Epilepsy prevalence in the 0-17 age group in trabzon, Turkey.

Authors:  Murat Topbaş; Sükrü Ozgün; Müjgan F Sönmez; Ayşe Aksoy; Gamze Can; Asuman Yavuzyilmaz; Emine Can
Journal:  Iran J Pediatr       Date:  2012-09       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.